Home › Compare › IRBS vs EQR

IRBS vs EQR: Dividend Comparison 2026

IRBS yields 3333333.33% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IRBS wins by $8.066963011092293e+41M in total portfolio value
10 years
IRBS
IRBS
● Live price
3333333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.066963011092293e+41M
Annual income
$806,648,697,106,848,200,000,000,000,000,000,000,000,000,000,000.00
Full IRBS calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — IRBS vs EQR

📍 IRBS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIRBSEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IRBS + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IRBS pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IRBS
Annual income on $10K today (after 15% tax)
$283,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$685,651,392,540,820,900,000,000,000,000,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, IRBS beats the other by $685,651,392,540,820,900,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IRBS + EQR for your $10,000?

IRBS: 50%EQR: 50%
100% EQR50/50100% IRBS
Portfolio after 10yr
$4.033481505546146e+41M
Annual income
$403,324,348,553,424,100,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

IRBS
No analyst data
Altman Z
-999.7
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IRBS buys
0
EQR buys
0
No recent congressional trades found for IRBS or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIRBSEQR
Forward yield3333333.33% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$8.066963011092293e+41M$47.8K ✓
Annual income after 10y$806,648,697,106,848,200,000,000,000,000,000,000,000,000,000,000.00 ✓$5,475.61
Total dividends collected$8.066931866681733e+41M$23.0K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: IRBS vs EQR ($10,000, DRIP)

YearIRBS PortfolioIRBS Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$333,344,033$333,333,333.33$11,380$679.82+$333.33M → IRBS
2$10,384,906,003,142$10,384,549,325,025.96$13,014$837.25+$10384905.99M → IRBS
3$302,363,748,270,118,850$302,352,636,420,695,500.00$14,961$1,036.20+$302363748270.10M → IRBS
4$8,227,619,721,265,916,000,000$8,227,296,192,055,268,000,000.00$17,297$1,289.22+$8227619721265916.00M → IRBS
5$209,235,859,949,820,440,000,000,000$209,227,056,396,718,700,000,000,000.00$20,121$1,613.15+$209235859949820444672.00M → IRBS
6$4,972,966,428,923,558,700,000,000,000,000$4,972,742,546,553,412,000,000,000,000,000.00$23,561$2,030.84+$4.972966428923559e+24M → IRBS
7$110,461,904,714,538,420,000,000,000,000,000,000$110,456,583,640,459,500,000,000,000,000,000,000.00$27,783$2,573.54+$1.1046190471453842e+29M → IRBS
8$2,293,122,282,540,014,600,000,000,000,000,000,000,000$2,293,004,088,301,970,000,000,000,000,000,000,000,000.00$33,013$3,284.39+$2.2931222825400146e+33M → IRBS
9$44,489,721,851,484,010,000,000,000,000,000,000,000,000,000$44,487,268,210,641,690,000,000,000,000,000,000,000,000,000.00$39,547$4,223.51+$4.448972185148401e+37M → IRBS
10$806,696,301,109,229,300,000,000,000,000,000,000,000,000,000,000$806,648,697,106,848,200,000,000,000,000,000,000,000,000,000,000.00$47,791$5,475.61+$8.066963011092293e+41M → IRBS

IRBS vs EQR: Complete Analysis 2026

IRBS — Stock

IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. The company, through its subsidiary, ImmuneRegen BioSciences, Inc., engages in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia. It is involved in the development of Homspera, and its derivates Radilex and Viprovex, for human stem cell stimulation, immune system stimulation and anti-infective activity, vaccine adjuvancy, and wound healing. IR BioSciences Holdings, Inc. was founded in 1999 and is headquartered in Scottsdale, Arizona.

Full IRBS Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this IRBS vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IRBS vs SCHDIRBS vs JEPIIRBS vs OIRBS vs KOIRBS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.